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1. Introduction  
1,2,3-Oxadiazolium-5-olates1 constitute the parent compounds 
of the sydnone family, the first member of which was unknowingly 
synthesized in 1935.2 Sydnone imines3 as well as sydnone 
methides4 are derivatives of sydnones with exocyclic nitrogen and 
carbon substituents instead of oxygen, respectively (Scheme 1). 
Considerable interest has been focused on sydnones as starting 
materials in synthetic organic chemistry1 (vide infra), potential 
drugs (antibiotics,5 anti-cancer compounds,6 antidiabetics,7 
antifungal,8 anti-inflammatory,9 anti-HIV agents10) and technical 
applications such as molecular imaging.11 In comparison to 
sydnones, much less is known about sydnone imines. Concerning 
the biological activity, the NO donor and vasodilating drug 
Molsidomine (Corvasal, Corvaton, Molsidain, Molsidolat), 
however, is a prominent and widely applied sydnone imine to 
which interest has been directed with respect to anti-
arrhythmogenic,12 anxiolytic,13 cardioprotective,14 and cerebral 
vasospasm-associated activities.15 Sydnone methides are 
extremely rare and, to the best of our knowledge, no information 
is available concerning the biological activities.16  
 
 
 
 
Scheme 1. The sydnone family of compounds 
All sydnone derivatives belong to the class of mesomeric 
betaines. These can exclusively be represented by canonical forms 
in which the positive and negative charges are delocalized within 
a common -electron system. According to a recent classification 
by Ramsden and Oziminski five distinct classes of mesomeric 
betaines can be distinguished by matrix-connectivity analyses.17 
Sydnones (Z = O) as well as sydnone imines (Z = NR) and sydnone 
methides (Z = CR2) belong to the class of conjugated mesomeric 
betaines (CMB). They can be represented by a number of 
canonical formulae some of which are shown in Scheme 2. In 
sydnone imines and sydnone methides, the delocalization of the 
negative charges is extended into the exocyclic substituent. 
 
 
 
 
 
 
 
Scheme 2. Some canonical formulae of sydnone derivatives. 
 
Characteristic of the class of conjugated mesomeric betaines 
common sites for either charge exist in the canonical formulae.18 
Most of the resonance forms suggest exocyclic double bonds, i.e. 
carbonyl groups (Z = O), imine groups (Z = NR), or exocyclic 
alkene groups (Z = CR2). For sydnones, these are in accordance 
with the results of single crystal X-ray analyses as well as 
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vibrational spectroscopic investigations which hint at a bond 
order of 1.99.19 In sydnone imines, the exocyclic C-N bond is 
usually slightly longer than the C=N double bond of imines.20 The 
characteristic dipole type of conjugated mesomeric betaines can 
also be dissected from the mesomeric structures of sydnone 
derivatives (Scheme 3). Indeed, sydnones 1 are known to be 
versatile masked 1,3-dipoles in cycloadditions.18 Thus, numerous 
acetylenes give pyrazoles 221 and regioselectivity studies have 
been performed.22 Alkenes mainly possessing electron-
withdrawing groups give 4,5-dihydro-1H-pyrazoles 3.23 
Cycloadditions of sydnones with heterocumulenes are rare. A 
photochemical synthesis of 1,2,4-triazol-3-one 4 with 
phenylisocyanate (R´ = Ph) was described, and carbon disulfide 
and carbon dioxide reacted similarly.24 It was furthermore reported 
that (2,2-dimethylpropylidyne)phosphane gave 3-(tert-butyl)-1-
methyl-1H-1,2,4-diazaphosphole 5 (R´ = Me).25 The valence 
tautomer 6, which was originally postulated as a structure of 
sydnones in 19352 and as an intermediate of the aforementioned 
photochemical reactions,24 was generated by a matrix photolysis.26 
Cycloadditions of sydnone imines (Z = NR) are very rare. Very 
recently they have attracted attention as masked 1,3-dipoles in 
cycloreactions with acetylenes.11,27 Thus, bioorthogonal click and 
release reactions of sydnone imines with cycloalkynes have been 
described28 and patented.29    
 
 
 
 
 
 
 
Scheme 3. Reactions involving the masked 1,3-dipole of 
sydnones. 
 
Upon deprotonation with suitable bases, anions of sydnones19,30 
as well as of sydnone imines31 are formed which can be 
represented as anionic N-heterocyclic carbenes (Scheme 4).19,20 
These undergo numerous trapping reactions (S,32,33 B,33 Se,34 Au,34 
Pd34). Nucleophilic ring transformations have also been reported.35 
Thus, sydnone and sydnone imine anions combine the features of 
N-heterocyclic carbenes due to their  lone pair and of conjugated 
mesomeric betaines due to their characteristic -architecture. 
Consequently, the highest occupied molecular orbitals (HOMO) 
which are -orbitals, display large atomic orbital coefficients on 
C4 which seem to be a common feature of the most of anionic N-
heterocyclic carbenes derived from mesoionic compounds.36 Some 
results have been summarized in review articles.37  
In continuation of our studies directed toward the chemistry of 
mesomeric betaines and their potential conversions into N-
heterocyclic carbenes, and as part of our studies directed toward 
the chemical and physical consequences of different types of 
conjugation, we describe herein reactions of sydnone imines 
which take advantage of the combination of - and -
characteristics of their anions.  
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Sydnone imine anions combine features of anionic N-
heterocyclic carbenes and -electron-rich heteroaromatics.  
 
2. Results and Discussion 
Deprotonation of the sydnone imines 7a-c by lithium 
bis(trimethylsilyl)amide at rt gave the sydnone imine anions 8a-c 
which were subsequently treated with diisoproyl azodicarboxylate 
(DIAD) to give the adducts 9a-c as a mixture of tautomers in 
moderate yields (Scheme 5). Under these conditions, the sydnone 
imine carbenes reacted as C-nucleophiles. To the best of our 
knowledge, no C-N bond formation starting from sydnone imines 
has been described so far, as the structure of 4-hydrazinosydnone, 
initially postulated, proved to be incorrect.38  
  
 
 
 
 
 
 
 
 
 
 
Scheme 5. Reaction of sydnone imines 7a-c with diisopropyl 
azodicarboxylate after deprotonation. 
 
The structures of the tautomers of 9a-c were confirmed by 2D-
HMBC NMR measurements. The major tautomers are 9a-cA. At 
room temperature the 1H NMR spectra display broad signals of the 
protons of the substituents (R), the protons of the diisopropyl 
groups and more than one broad signal for the proton involved in 
tautomerism. For further investigations we performed NMR 
experiments in the temperature range of 25 °C to 80 °C in 
anhydrous deuterated DMSO. With increasing temperature just 
one signal of the proton involved in tautomerism can be observed, 
while the aforementioned broad signals become more and more 
defined, resulting in sharp multiplets at 80 °C. Upon cooling to 25 
°C, the signal broadening proved to be reproducible. Suitable 
crystals for single crystal X-ray analysis were obtained by cooling 
a saturated solution of the compound in a DMSO-water mixture 
(10:1). The molecular drawing (Fig. 1) shows a strong hydrogen 
bond between N23-H and the O7 oxygen atom (N23-H…..O7 = 
206(1) pm), indicating a possible tautomeric structure 9aC as 
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shown in Scheme 3. In solutions with free bond rotations the 
tautomeric structures 9a-cC are also highly probable. The 
molecule crystallized monoclinic. Results of the X-ray analysis 
show an almost planar alignment between the oxadiazole ring and 
the exocyclic imine group, as a torsion angle of 6° was found. The 
2-methoxyphenyl ring is twisted by 83° which cause an interrupted 
-conjugation. Hydrogen bonding (N23-H…..O7) is out of plane 
and the N-CO2
iPr groups are twisted by 85° towards each other.   
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Molecular drawing of C4-substituted sydnone imine 
9aA (displacement parameters are drawn at the 50% probability 
level). Selected bond lengths [pm] (crystallographic numbering): 
O1-N2: 137.43(12), N2-N3: 129.98(13), N3-C4: 136.08(14), C4-
C5: 140.40(15), O1-C5: 138.68(13), C5-N6: 131.01(15), N6-C7: 
136.48(14), C7-O7: 123.17(14), C4-N22: 139.34(14), N22-N23: 
138.58(12), N23-H23—O7: 206(1) pm. 
 
Reductive 1,3-dipolar cycloadditions of the sydnone imine 
anions 8a-c require a nucleophilic C4 position plus a participating 
-conjugative system to intercept the resulting terminal anion. We 
performed these reactions starting from freshly prepared 4-
sydnone imine anions 8a-c and tetracyanoethylene (TCNE) in 
anhydrous THF at room temperature and obtained the pyrazoles 
10a-c in good yields (Scheme 6). No reaction of the sydnone 
imines 7a-c and TCNE in the absence of base can be observed. 
Even at elevated temperatures in anhydrous THF at 65 °C or in 
anhydrous toluene at reflux and prolonged reaction times of 6 h no 
cycloaddition (G) or cycloreaction products can be found starting 
from 7a-c. We propose the following mechanism: nucleophilic 
attack at the C4 position of 8a-c gives the terminal anions D which 
induce a ring transformation by attack at N2 to give intermediate 
E. Formation of cyanogen from E and F results in the formation 
of the heteroaromatic pyrazole, possessing an N-carbonyl 
benzamide substituent, under charge neutralization. 
Structure determination was accomplished by X-ray analysis 
from single crystals of 10a and 10c (Figs. 2 and 3). Suitable single 
crystals were obtained by slow evaporation of a saturated solution 
from a chloroform-hexane mixture, respectively. Although both 
single crystals show closely related bond lengths and bond angles, 
the crystallization adopts different Bravais lattices and space 
groups (monoclinic, P21/c for 10a and orthorhombic, P212121 for 
10c). Furthermore, varying torsion angles are observed between 
the pyrazole and the carbonylbenzamide fragments (46° for 10a, 
36° for 10c), as well as the pyrazole ring and the N1-nitrogen 
substituents (49° for 10a, 74° for 10c).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6. Reaction of sydnone imines 7a-c with 
tetracyanoethylene via their anions 8a-c 
 
 
 
 
 
 
 
 
Figure 2. Molecular drawing of pyrazole 10a (displacement 
parameters are drawn at the 30% probability level). Selected bond 
lengths [pm] (crystallographic numbering): N1-N2: 134.79(13), 
N2-C3: 132.58(15), C3-C4: 140.73(16), C4-C5: 137.93(16), N1-
C5: 135.65(13), C5-C6: 149.23(15), C6-O6: 121.24(13), C6-N7: 
136.84(14), N7-C8: 139.59(15), C8-O8: 120.75(15), C3-C31: 
143.07(17), C31-N31: 112.96(18), C4-C41: 142.28(16), C41-
N41: 113.74(17) pm. 
 
 
 
 
 
 
 
 
 
Figure 3. Molecular drawing of pyrazole 10c (displacement 
parameters are drawn at the 30% probability level). Selected bond 
lengths [pm] (crystallographic numbering): N1-N2: 134.3(2), N2-
C3: 132.8(2), C3-C4: 139.9(3), C4-C5: 138.7(3), N1-C5: 135.7(2), 
C5-C6: 148.6(2), C6-O6: 120.4(2), C6-N7: 139.0(2), N7-C8: 
139.4(2), C8-O8: 121.0(3), C3-C31: 143.3(3), C31-N31: 113.9(3), 
C4-C41: 142.4(3), C41-N41: 113.7(3) pm. 
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In contrast to the aforementioned literature-known 
cycloreactions of sydnone imines with alkynes by Audisio, Taran 
and co-workers, which proceeded by extrusion of CO2 and the 
former exocyclic NR group of the sydnone imine as RNH2, the 
reactions described here proceed via the formation of a 
thermodynamically stable fragment R3-R3 (R3 = CN) from the 
dipolarophile (Scheme 7). All other atoms of the starting materials 
remain in the final products. 
 
 
 
 
 
Scheme 7. Comparison: two types of pyrazole formation. 
 
Next, we tried reactions of the sydnone imine anions 8a-c with 
N,N-diisopropylcarbodiimide. Indeed, the 2-methoxyphenyl 
substituted sydnone imine underwent a reaction to give a new class 
of bisiminonitriles with an intense yellow color. However, the 
yield is low and the derivatives 7b,c did not react under analogous 
reaction conditions. We postulate the following mechanism: initial 
attack at the C4 position of 8a gives a terminal anion which attacks 
the benzoyl group of the former sydnone imine. This results in the 
formation of the product 11a and the instable39 nitroxyl anion 
(Scheme 8). 
 
 
 
  
 
 
 
 
 
Scheme 8. Reaction of sydnone imines 7a-c with DIC. 
 
The structure of 11a was confirmed by single crystal X-ray 
analysis (Fig. 4). Single crystals were obtained by slow 
evaporation from chloroform. Interestingly, the two imines differ 
in their stereoisomerism. The N1-C2 imine function shows the E-
isomer and the C3-N31 imine displays Z-isomerism.  
 
 
Figure 4. Molecular drawing of bisiminonitrile 11a 
(displacement parameters are drawn at the 50% probability level). 
Selected bond lengths [pm] (crystallographic numbering): N1-C2: 
127.19(14), C2-C3: 149.52(15), C3-N4: 143.29(13), N4-C5: 
137.57(14), C5-O5: 122.71(13), C3-N31: 126.66(14), C2-C21: 
146.49(15), C21-N21: 114.51(15) pm. 
 
3. Conclusion 
Sydnone imine anions combine the features of anionic N-
heterocyclic carbenes and of mesoionic compounds. They  
undergo trapping reactions in which they act as C-nucleophiles 
toward DIAD. Upon treatment with TCNE, the initial nucleophilic 
attack results in the formation of a terminal anion which induces a 
cycloreaction with the formation of pyrazoles.  
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